title: Guanfacine extended release in two patients with pervasive developmental disorders.
authors.forename: Kelly
authors.initials: K
authors.lastname: Blankenship
authors.forename: Craig A
authors.initials: CA
authors.lastname: Erickson
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Stigler
authors.forename: David J
authors.initials: DJ
authors.lastname: Posey
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: McDougle
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy*; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D005260:Female; D016316:Guanfacine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D003692:Delayed-Action Preparations; D016316:Guanfacine